- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
AstraZeneca wins over UK doctors
10 September 2009
Medical representatives from AstraZeneca came out top with UK doctors in a survey conducted by Doctors.net.uk.
More than 600 primary and secondary care doctors were asked to vote for representatives they valued in terms of communication skills, technical skills as well as for those they most enjoyed meeting. AstraZeneca was the most highly rated but a number of smaller firms also did well compared with the bigger companies, including Takeda, Ferring and Eisai.
The complete Top Ten are as follows: Eli Lilly, Pfizer, GlaxoSmithKline, Janssen Cilag, Sanofi-aventis, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb and Merck Sharpe & Dohme.
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
